Rizatriptan Benzoate
Thông số
145202-66-0Số CAS
604-465-6Số EC
benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamineTên IUPAC
C22H25N5O2Công thức hóa học
391.5 g/molKhối lượng phân tử
Rizatriptan benzoate; 145202-66-0; Maxalt-MLT; RIZAFILM; WR978S7QHH; NSC-758919; L 705126; L 705,126; L-705,126; DTXSID20162937; 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoate; SYMBRAVO COMPONENT RIZATRIPTAN BENZOATE; 3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate; 3-[2-(Dimethylamino)ethyl]-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate; RefChem:58236; Rizatriptan Benzoate ODT; DTXCID8085428; 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, benzoate (1:1); 604-465-6; Maxalt; Rizatriptan (benzoate); MK 462; MK-0462; MFCD00866224; N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate; Rizatriptan Benzoate (Maxalt); 2-(5-((1H-1,2,4-triazol-1-yl)methyl)-1H-indol-3-yl)-N,N-dimethylethan-1-amine benzoate; benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; S1607; Rizatriptanbenzoate; Rizatriptan Benzoate [USAN]; UNII-WR978S7QHH; MK 0462; Rizatriptan benzoate [USAN:USP]; rizatrimptan benzoate; rizatriptane benzoate; rizatriptan, benzoate; Rizatriptan benzoate CRS; N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE BENZOATE; SCHEMBL41226; MLS001424197; CHEBI:8875; orb1226245; orb1308386; SCHEMBL3002162; CHEMBL1201032; HY-B0206R; Rizatriptan benzoate (JAN/USP); RHB-103; RIZATRIPTAN BENZOATE [MI]; JPRXYLQNJJVCMZ-UHFFFAOYSA-N; GLXC-05242; HMS2051B16; HMS2093K08; HMS2235M18; HMS3369I15; HMS3393B16; HMS3655K09; HMS3715D08; HMS3884K21; HMS5079M18; Pharmakon1600-01505189; Rizatriptan (benzoate) (Standard); RIZATRIPTAN BENZOATE [JAN]; HY-B0206; INT-0008; RIZATRIPTAN BENZOATE [VANDF]; AC-734; EBC-11267; NSC758919; RIZATRIPTAN BENZOATE [MART.]; RIZATRIPTAN BENZOATE [USP-RS]; RIZATRIPTAN BENZOATE [WHO-DD]; AKOS015855933; Rizatriptan for system suitability CRS; AB07521; CCG-101039; FR27745; KS-1189; NC00289; NSC 758919; RIZATRIPTAN BENZOATE [ORANGE BOOK]; SMR000525252; RIZATRIPTAN BENZOATE [EP MONOGRAPH]; DB-015783; RIZATRIPTAN BENZOATE [USP MONOGRAPH]; Rizatriptan benzoate salt, >=98% (HPLC); R0107; R0181; SW197669-2; D00675; F300988; SR-01000763588; SR-01000763588-3; Q27292788; Rizatriptan benzoate, European Pharmacopoeia (EP) Reference Standard; Rizatriptan benzoate, United States Pharmacopeia (USP) Reference Standard; DIMETHYL-[2-(5-[1,2,4]TRIAZOL-1-YLMETHYL-1H-INDOL-3-YL)-ETHYL]-AMINE BENZOATE; Rizatriptan for system suitability, European Pharmacopoeia (EP) Reference Standard; Benzoic acid--N,N-dimethyl-2-{5-[(1H-1,2,4-triazol-1-yl)methyl]-1H-indol-3-yl}ethan-1-amine (1/1)Tên gọi khác
Sản phẩm chứa Rizatriptan Benzoate
MAXALT MAX 10 MG LIOFILIZADO ORALMAXALT 10 MG COMPRIMIDOSMAXALT 10 MG COMPRIMIDOSMAXALT MAX 10 mg LIOFILIZADO ORALMAXALT MAX 10 mg LIOFILIZADO ORALMAXALT MAX 10 mg LIOFILIZADO ORALMAXALT MAX 10 mg LIOFILIZADO ORALMAXALT MAX 10 mg LIOFILIZADO ORALMAXALT MAX 10 MG LIOFILIZADO ORALMAXALT MAX 10 MG LIOFILIZADO ORALMAXALT MAX 10 MG LIOFILIZADO ORALMAXALT MAX 10 MG LIOFILIZADO ORAL
Trang 1/6
Công ty đang bán Rizatriptan Benzoate
AP
Aurobindo Pharma LimitedIndiaMP
Macleods Pharmaceuticals LimitedIndiaTrang 1/4